0000000000323205

AUTHOR

E. Alonso

showing 3 related works from this author

Penicillium auxotrophic mutants can be detected by suing xanthene dyes

1987

Auxotrophic mutants ofPenicillium spp. have been directly isolated after mutagenic treatment from agar plates containing Xanthene dyes. They grow as characteristic small colored colonies. Some strains were tested and they showed a differential response depending on the Xanthene dye used.

PharmacologyXanthenebiologyAuxotrophyMutagenesis (molecular biology technique)Cell BiologyFungi imperfectibiology.organism_classificationAgar plateCellular and Molecular Neurosciencechemistry.chemical_compoundchemistryBiochemistryXanthene dyePenicilliumAuxotrophic mutantMolecular MedicineMolecular BiologyExperientia
researchProduct

Global transcriptome deregulation of breast cancer in very young women samples

2017

0301 basic medicineOncologymedicine.medical_specialtybusiness.industryHematologymedicine.diseaseTranscriptome03 medical and health sciencesDeregulation030104 developmental biologyBreast cancerOncologyInternal medicinemedicinebusinessAnnals of Oncology
researchProduct

Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma

2021

BACKGROUND: Various studies have assessed omalizumab outcomes in the clinical practice setting but follow-up and/or number of patients included were limited. We aim to describe the long-term outcomes of pediatric patients with severe persistent allergic asthma receiving omalizumab in the largest real-life cohort reported to date. METHODS: ANCHORS was a multicenter, observational, retrospective cohort study conducted in 25 Pediatric Allergy and Pulmonology units in Spain. We collected data of patients < 18 years and initiating omalizumab between 2006 and 2018, from the year prior to omalizumab initiation to discontinuation or last available follow-up. The primary outcome was the evolution of…

severe asthmamedicine.medical_specialtyPediatricsImmunology*real lifeOmalizumabhumanized monoclonal antibodiesOmalizumab*adolescentsAntibodies Monoclonal HumanizedAnti-asthmatic Agent03 medical and health sciences0302 clinical medicinechildrenreal lifeInternal medicinemedicine*anti-asthmatic agents*childrenHumansImmunology and AllergyChildren adolescents anti-asthmatic agents humanized monoclonal antibodies observational study omalizumab real-life severe asthmaAnti-Asthmatic Agentsadolescents030212 general & internal medicineChildAdverse effectRetrospective Studiesbusiness.industryasthmatic agents*observational studyanti&#8208Retrospective cohort studyAsthmaDiscontinuation*omalizumabTreatment OutcomePulmonology030228 respiratory system*humanized monoclonal antibodies*severe asthmaSevere persistent allergic asthmaPediatrics Perinatology and Child HealthCohortomalizumabobservational studyObservational studybusinessmedicine.drugPediatric Allergy and Immunology
researchProduct